{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008283",
      "entity_text" : "proliferation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00271",
      "entity_text" : "bufalin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Accumulating evidence suggests bufalin could inhibit the proliferation of multiple tumor cell types, including human colon cancer cells (colon, 26-L5), leukemia cells (K562, U937, ML1 and HL-60), hepatocellular carcinoma cells (SMMC-7721 and Bel-7402), prostate cancer cells (LNCaP, DU 145 and PC3), endometrial carcinoma cells (HHUA and HEC-1), and ovarian cancer cells (SK-OV3 and omc-3).",
  "reading_complete" : "2020-08-04T09:15:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:13:54Z",
  "trigger" : "inhibit",
  "evidence" : [ "bufalin could inhibit the proliferation" ],
  "pmc_id" : "5665466",
  "score" : 0
}